The Effectiveness of Dexmedetomidine as an Adjuvant for Bupivacaine Caudal Block in Pediatric Open Appendectomy Under General Anesthesia

NCT07088900 — Not applicable, Recruiting, 60 participants, Ain Shams University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT07088900
StatusRecruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, prevention
Enrollment60 (Estimated)
SponsorAin Shams University (Other)
ConditionsAppendectomy, Pediatric
Interventionscaudal block using dexmedetomidine with bupivacaine, caudal block with bupivacaine (Procedure)
Datesstart 2025-08-01, primary completion 2026-06-30 (estimated), completion 2026-07-30 (estimated), first posted 2025-07-28, last updated 2026-05-06
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
All trials for Appendectomy All trials for Pediatric All trials of caudal block using dexmedetomidine with bupivacaine All trials of caudal block with bupivacaine

-Summary

This study aims to evaluate if adding dexmedetomidine to bupivacaine in a caudal block can provide longer and better quality pain relief for children after open appendectomy surgery. The study will also assess the effect of this combination on the quality of recovery, including the incidence of emergence delirium, and its overall safety profile.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Control GroupActive comparatorProcedure: caudal block with bupivacainePatients will receive a single-shot caudal block with 1 mL/kg of 0.25% bupivacaine mixed with 1 mL of normal saline.
Experimental GroupExperimentalProcedure: caudal block using dexmedetomidine with bupivacainePatients will receive a single-shot caudal block with 1 mL/kg of 0.25% bupivacaine mixed with 1 µg/kg of dexmedetomidine (diluted in 1 mL of normal saline).
  • caudal block using dexmedetomidine with bupivacaine (Procedure): Patients will receive a single-shot caudal block with 1 mL/kg of 0.25% bupivacaine mixed with 1 µg/kg of dexmedetomidine (diluted in 1 mL of normal saline).
  • caudal block with bupivacaine (Procedure): Patients will receive a single-shot caudal block with 1 mL/kg of 0.25% bupivacaine mixed with 1 mL of normal saline

+Outcome measures

Primary outcomes

  • Time to First Rescue Analgesia: [Up to 24 hours post-caudal block]: Defined as the time interval in minutes from the performance of the caudal block until the first administration of rescue analgesia (ibuprofen), which is prompted by a FLACC pain score of ≥ 4.

+Eligibility

Sex: All, ages: 2 Years to 7 Years

inclusion criteria:

* ASA (American Society of Anesthesiologists) physical status I or II.
* Legal guardian provides written informed consent. Exclusion Criteria
* Refusal of participation by the legal guardian.
* Known allergy or hypersensitivity to local anesthetics or dexmedetomidine.
* Coagulation disorder or receiving anticoagulant therapy.
* Active infection at or near the injection site.
* Significant anatomical abnormalities of the lumbosacral spine.
* Pre-existing neurological disorders, psychiatric disorders, or a history of convulsions.
* Anticipated surgery time of more than 2.5 hours.
* Patients with severe asthma or active wheezing.

+Locations (1)

FacilityCityCountryStatus
Ain Shams university hospitalsCairoEgyptRecruiting